Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor That Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model.
Journal of Medicinal Chemistry(2021)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Medicinal Chemistry(2021)